Glucocorticoid modulates angiotensin ii receptor expression patterns and protects the heart from ischemia and reperfusion inj

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Xue, Qin ^a   Patterson, Andrew J ^a   Xiao, Daliao ^a   Zhang, Lubo ^a  

^a Center for Perinatal Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PROTEIN KINASE C EPSILON; ANGIOTENSIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPERFUSION INJURY; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; DRUG EFFECTS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; DEXAMETHASONE; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; MALE; MYOCARDIAL REPERFUSION INJURY; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANGIOTENSIN; REPERFUSION INJURY; UP-REGULATION;

EID: 84907484140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106827     Document Type: Article

References (44)

1. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 21: 55-89
2. Dumont A, Hehner SP, Schmitz ML, Gustafsson JA, Liden J, et al. (1998) Crosstalk between steroids and NF-kappa B: what language? Trends Biochem Sci. 23: 233-235
3. Chen QM, Alexander D, Sun H, Xie L, Lin Y, et al. (2005) Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: induction of antiapoptosis, antioxidant, and detoxification genes. Mol Pharmacl. 67: 1861-1873
4. Engelman RM, Prasad MR, Rousou JA, Breyer RH, Bagchi M, et al. (1989) Steroid-induced myocardial preservation is associated with decreased cell membrane microviscosity. Circulation 80: III36-43
5. Nussinovitch U, de Carvalho JF, Pereira RM, Shoenfeld Y (2010) Glucocorticoids and the cardiovascular system: state of the art. Curr Pharmaceut Design. 16: 3574-3585
6. Seckl JR (2004) Prenatal glucocorticoids and long-term programming. Eur J Endocrinol. 151 Suppl 3: U49-62
7. Valen G, Kawakami T, Tahepold P, Dumitrescu A, Lowbeer C, et al. (2000) Glucocorticoid pretreatment protects cardiac function and induces cardiac heat shock protein 72. Am J Physiol Heart Circ Physiol. 279: H836-H843
8. Varga E, Nagy N, Lazar J, Czifra G, Bak I, et al. (2004) Inhibition of ischemia/ reperfusion-induced damage by dexamethasone in isolated working rat hearts: the role of cytochrome c release. Life Sci. 75: 2411-2423
9. Fan WJ, Genade S, Genis A, Huisamen B, Lochner A (2009) Dexamethasoneinduced cardioprotection: a role for the phosphatase MKP-1? Life Sci. 84: 838-846
10. Duma D, Jewell CM, Cidlowski JA (2006) Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol. 102: 11-21
11. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68: 450-456
12. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 74: 196-206
13. Billet S, Aguilar F, Baudry C, Clauser E (2008) Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidn Intern. 74: 1379-1384
14. Rush JW, Aultman CD (2008) Vascular biology of angiotensin and the impact of physical activity. Appl Physiol. 33: 162-172
15. Dasgupta C, Zhang L (2011) Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today 16: 22-34
16. Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 83: 1182-1191
17. Yamada T, Horiuchi M, Dzau VJ (1996) Angiotensin II type 2 receptor mediates programmed cell death. Proc Nat Acad Sci 93: 156-160
18. Guo DF, Uno S, Ishihata A, Nakamura N, Inagami T (1995) Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter. Circ Res. 77: 249-257
19. Bogdarina IG, King PJ, Clark AJ (2009) Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids. J Mol Endocrinol 43: 73-80
20. Xue Q, Dasgupta C, Chen M, Zhang L (2011) Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc Res. 89: 300-308
21. Meyer K, Zhang H, Zhang L (2009) Direct effect of cocaine on epigenetic regulation of PKCe gene repression in the fetal rat heart. J Mol Cell Cardiol 47: 504-511
22. Patterson AJ, Chen M, Xue Q, Xiao D, Zhang L (2010) Chronic prenatal hypoxia induces epigenetic programming of PKCe gene repression in rat hearts. Circ Res 107: 365-373
23. Valen G, Kawakami T, Tahepold P, Starkopf J, Kairane C, et al. (2000) Pretreatment with methylprednisolone protects the isolated rat heart against ischaemic and oxidative damage. Free Radi Res 33: 31-43
24. Roy SG, De P, Mukherjee D, Chander V, Konar A, et al. (2009) Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway.x Cardiovasc Res. 24: 1-10
25. Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, et al. (2009) Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest. 119: 1477-1488
26. Ford WR, Clanachan AS, Jugdutt BI (1996) Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation 94: 3087-3089
27. Ford WR, Clanachan AS, Lopaschuk GD, Schulz R, Jugdutt BI (1998) Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function. Am J Physiol 274: H1524-1531
28. Booz GW (2004) Cardiac angiotensin AT2 receptor: what exactly does it do? Hypertension 43: 1162-1163
29. Segar JL, Scholz TD, Bedell KA, Smith OM, Huss DJ, et al. (1997) Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep. Am J Physiol 273: R1501-1508
30. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, et al. (1997) Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 95: 1193-1200
31. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, et al. (1998) Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res. 83: 1035-1046
32. Karnik SS, Unal H (2012) Angiotensin II receptor-induced cardiac remodeling in mice without angiotensin II. Hypertension. 59: 542-4
33. Yasuda N, Akazawa H, Ito K, Shimizu I, Kudo-Sakamoto Y, et al. (2012) Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice. Hypertension. 59: 627-33
34. Diaz RJ, Wilson GJ (1997) Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 29: 129-139
35. Liu Y, Tsuchida A, Cohen MV, Downey JM (1995) Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883-892
36. Xu Y, Clanachan AS, Jugdutt BI (2000) Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension. 36: 506-510
37. Maddali KK, Korzick DH, Turk JR, Bowles DK (2005) Isoform-specific modulation of coronary artery PKC by glucocorticoids. Vasc Pharmacol. 42: 153-162
38. Ping P, Song C, Zhang J, Guo Y, Cao X, et al. (2002) Formation of protein kinase Ce-Lck signaling modules confers cardioprotection. J Clin Invest. 109: 499-507
39. Gray MO, Karliner JS, Mochly-Rosen D (1997) A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxiainduced cell death. J Biol Chem. 272: 30945-30951
40. Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M (1998) Ischemic preconditioning translocates PKC-d and -e, which mediate functional protection in isolated rat heart. Am J Physiol. 275: H2266-2271
41. Baxter GF, Ferdinandy P (2001) Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol. 96: 329-344
42. Zhao TC, Taher MM, Valerie KC, Kukreja RC (2001) p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS. Circ Res. 89: 915-922
43. Chen L, Hahn H, Wu G, Chen CH, Liron T, et al. (2001) Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Nat Acad Sci. 98: 11114-11119
44. Zhang MZ, Yao B, Cheng HF, Wang SW, Inagami T, et al. (2006) Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors. Proc Nat Acad Sci. 103: 16045-16050